Cargando…

Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical Protocol

The purpose of this study was to compare the efficacies of one initial intravitreal injection of aflibercept followed by a pro re nata (PRN; 1+PRN) regimen to those of three consecutive monthly injections followed by the PRN (3+PRN) regimen for diabetic macular edema (DME) with practical protocols....

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayashi, Yuko, Tatsumi, Tomoaki, Oshitari, Toshiyuki, Kaiho, Tomomi, Takatsuna, Yoko, Arai, Miyuki, Baba, Takayuki, Yamamoto, Shuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896872/ https://www.ncbi.nlm.nih.gov/pubmed/33628832 http://dx.doi.org/10.1155/2021/1374891

Ejemplares similares

Efficacy of One-Year Treatment with Aflibercept for Diabetic Macular Edema with Practical Protocol
por: Kaiho, Tomomi, et al.
Publicado: (2017)

Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
por: Tatsumi, Tomoaki, et al.
Publicado: (2022)

Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
por: Shimizu, Norihiro, et al.
Publicado: (2017)

Effects of Switching from Anti-VEGF Treatment to Triamcinolone Acetonide in Eyes with Refractory Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion
por: Tatsumi, Tomoaki, et al.
Publicado: (2020)

Effects of sub-Tenon’s capsule triamcinolone acetonide injection combined with microaneurysm photocoagulation on diabetic macular edema
por: Oshitari, Toshiyuki, et al.
Publicado: (2015)

The effect of posterior sub-Tenon’s capsule triamcinolone acetonide injection to that of pars plana vitrectomy for diabetic macular edema
por: Nonomura, Sakiko, et al.
Publicado: (2014)

Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus
por: Tatsumi, Tomoaki, et al.
Publicado: (2022)

Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon's Capsule Triamcinolone Acetonide Injection
por: Oshitari, Toshiyuki, et al.
Publicado: (2015)

Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
por: Takatsuna, Yoko, et al.
Publicado: (2020)

Case of retinal detachment due to retinal break splitting macula vertically in a patient with cognitive disorder
por: Baba, Takayuki, et al.
Publicado: (2011)

Four Cases of Rhegmatogenous Retinal Detachment That Recurred More than 10 Years after Initial Reattachment by Pars Plana Vitrectomy
por: Baba, Takayuki, et al.
Publicado: (2021)

Werner syndrome with refractory cystoid macular edema and immunohistochemical analysis of WRN proteins in human retinas
por: Oshitari, Toshiyuki, et al.
Publicado: (2014)

Pathogenesis and Management of Macular Hole: Review of Current Advances
por: Bikbova, Guzel, et al.
Publicado: (2019)

Regional Reduction of Ganglion Cell Complex after Vitrectomy with Internal Limiting Membrane Peeling for Idiopathic Macular Hole
por: Baba, Takayuki, et al.
Publicado: (2014)

Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial
por: Ishibashi, Ryoichi, et al.
Publicado: (2020)

Macular Hole after Laser In Situ Keratomileusis in a 26-Year-Old Patient
por: Bikbova, Guzel, et al.
Publicado: (2013)

Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
por: Sugimoto, Masahiko, et al.
Publicado: (2022)

Development of Macular Holes after Rhegmatogenous Retinal Detachment Repair in Japanese Patients
por: Shibata, Mamiko, et al.
Publicado: (2012)

Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes
por: Sugimoto, Masahiko, et al.
Publicado: (2022)

The role of aflibercept in the management of diabetic macular edema
por: Chang, Andrew A, et al.
Publicado: (2015)

The clinical utility of aflibercept for diabetic macular edema
por: Stewart, Michael W
Publicado: (2015)

Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
por: Murakami, Tomoya, et al.
Publicado: (2022)

Real-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month Outcomes
por: Shimura, Masahiko, et al.
Publicado: (2022)

The efficacy and safety of aflibercept and conbercept in diabetic macular edema
por: Cai, Siwei, et al.
Publicado: (2018)

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
por: Klein, Kendra A., et al.
Publicado: (2017)

Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice
por: Campos Polo, Rafael, et al.
Publicado: (2018)

Current Treatments for Diabetic Macular Edema
por: Tatsumi, Tomoaki
Publicado: (2023)

Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema
por: Mori, Yuki, et al.
Publicado: (2017)

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
por: Lim, Laurence S, et al.
Publicado: (2015)

Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
por: Ohara, Hiromi, et al.
Publicado: (2023)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran, Thi Ha Chau, et al.
Publicado: (2021)

Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran, Thi Ha Chau, et al.
Publicado: (2022)

Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
por: Nawar, Amin E., et al.
Publicado: (2022)

Altered Expression of NF-κB and SP1 after Exposure to Advanced Glycation End-Products and Effects of Neurotrophic Factors in AGEs Exposed Rat Retinas
por: Bikbova, Guzel, et al.
Publicado: (2015)

Neuronal Changes in the Diabetic Cornea: Perspectives for Neuroprotection
por: Bikbova, Guzel, et al.
Publicado: (2016)

Flicker electroretinograms of eyes with cataract recorded with RETeval system before and after mydriasis
por: Miura, Gen, et al.
Publicado: (2018)

Comparisons of Visual and Surgical Outcomes after Reuse or Replacement of Dislocated in-the-Bag Intraocular Lens
por: Baba, Takayuki, et al.
Publicado: (2018)

Combination of Neuroprotective and Regenerative Agents for AGE-Induced Retinal Degeneration: In Vitro Study
por: Bikbova, Guzel, et al.
Publicado: (2017)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose, Remya, et al.
Publicado: (2016)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ruajh1d6k9k7kdfsolg7g4n5f5